News
2024-05-17
Cellectricon and Fluicell initate collaboration to validate tissue-based in vitro models
We’re excited to be working with Fluicell AB and support their development of bioprinted tissues for use in research and...
Events
May 27-28, 2024
Neuro4D 2024
The Neuro4D conference takes place in Mainz, Germany on May 27-28, 2024. With a focus on drug discovery for proteopathic...
Events
May 22-23, 2024
Discovery Europe
Discovery Europe and the Neuroscience Drug Development Europe meetings take place in parallel in Basel, Switzerland on May 22-23, 2024....

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
May 8-10, 2024
BIO KOREA
BIO KOREA takes place in Seoul, South Korea on May 8-10, 2024. Cellectricon will be part of the Swedish biopharma...
Events
March 25-27, 2024
Neuroimmunology Drug Development Summit
The 6th Neuroimmunology Drug Development Summit takes place in Boston, US on March 25-27. As a leading provider of neurobiology...
News
2024-03-12
Cellectricon launches Neuroinflammation Research Service
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has launched the Neuroinflammation Research Service module. Established...

Sign up to get news & events updates from Cellectricon

Read about our Privacy Policy

Events
March 5-9, 2024
AD/PD 2024
The AD/PD 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders takes place in Lisbon, Portugal on...
News
2024-02-20
Dr. Jonathan Levenson joins Cellectricon’s advisory board
Cellectricon has appointed Dr. Jonathan Levenson, Chief Scientific Officer at FireCyte Therapeutics, to its Scientific Advisory Board. Dr. Levenson brings...
News
2024-02-15
Cellectricon’s expertise in pain research recognized by second EU research grant
MÖLNDAL, SWEDEN Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, has received follow-on funding for bone pain research...